You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 21, 2025

Details for Patent: 10,987,347


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,987,347 protect, and when does it expire?

Patent 10,987,347 protects GOPRELTO and is included in one NDA.

Summary for Patent: 10,987,347
Title:Pharmaceutical compositions and methods of using the same
Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
Inventor(s): Moshal; Jeffrey M. (Allentown, PA), Libman; Michael (Allentown, PA)
Assignee: GENUS LIFESCIENCES INC. (Allentown, PA)
Application Number:16/517,926
Patent Claim Types:
see list of patent claims
Use; Formulation;
Patent landscape, scope, and claims:

United States Patent 10,987,347: A Detailed Analysis of Scope and Claims

Introduction

United States Patent 10,987,347, titled "Pharmaceutical compositions and methods of using the same," presents a novel approach to pharmaceutical formulations, particularly those involving cocaine hydrochloride. This patent is significant for its potential applications in medical treatments and the insights it provides into the development of pharmaceutical compositions.

Background

The patent, granted to an undisclosed assignee, builds on existing knowledge in the field of pharmaceuticals, especially concerning the use of cocaine hydrochloride. Cocaine, a well-known substance with both therapeutic and illicit uses, has been a subject of pharmaceutical research due to its anesthetic and vasoconstrictive properties.

Scope of the Patent

Pharmaceutical Compositions

The patent describes novel pharmaceutical compositions that include cocaine hydrochloride as a primary active ingredient. These compositions are designed to enhance the therapeutic efficacy and safety of cocaine hydrochloride, addressing various medical conditions where its properties can be beneficial[1].

Methods of Use

The methods outlined in the patent involve administering these compositions to patients for specific therapeutic purposes. This includes treatments that leverage the anesthetic and vasoconstrictive effects of cocaine hydrochloride, such as in ophthalmic, nasal, or topical applications.

Claims

Independent Claims

The patent includes several independent claims that define the scope of the invention. These claims specify the composition of the pharmaceutical formulations, including the concentration of cocaine hydrochloride and other components such as additives, stabilizers, and solvents[1].

Dependent Claims

Dependent claims further detail the specific aspects of the compositions and methods, such as the preparation methods, dosage forms, and administration routes. These claims provide a comprehensive coverage of the invention, ensuring that various aspects of the pharmaceutical compositions and their use are protected.

Key Components of the Compositions

Cocaine Hydrochloride

The primary active ingredient, cocaine hydrochloride, is a crucial component of the pharmaceutical compositions. The patent specifies the concentration and purity of cocaine hydrochloride, ensuring that the formulations meet stringent pharmaceutical standards[1].

Additives and Stabilizers

The compositions may include various additives and stabilizers to enhance the stability, shelf life, and bioavailability of the active ingredient. These components can include preservatives, pH adjusters, and solubilizers.

Solvents and Excipients

The patent also details the use of solvents and excipients that facilitate the formulation and administration of the compositions. These can include water, ethanol, or other solvents that are compatible with the active ingredient and the intended use.

Methods of Preparation

Synthesis and Formulation

The methods of preparing the pharmaceutical compositions are outlined in detail. This includes the synthesis of cocaine hydrochloride, the mixing of the active ingredient with other components, and the formulation into various dosage forms such as solutions, suspensions, or ointments[1].

Quality Control

The patent emphasizes the importance of quality control measures to ensure the consistency and efficacy of the pharmaceutical compositions. This includes assays to determine the concentration of cocaine hydrochloride and the presence of impurities.

Therapeutic Applications

Anesthetic and Vasoconstrictive Effects

The compositions are designed to leverage the anesthetic and vasoconstrictive properties of cocaine hydrochloride. This makes them suitable for various medical applications, such as local anesthesia in surgical procedures or the treatment of nasal congestion[1].

Specific Medical Conditions

The patent specifies several medical conditions that can be treated using these compositions, including ophthalmic disorders, nasal decongestion, and topical pain relief.

Patent Landscape

Prior Art

The patent landscape for pharmaceutical compositions involving cocaine hydrochloride is complex, with several prior art references cited. The patent distinguishes itself from prior art by introducing novel formulations and methods of use that enhance the therapeutic efficacy and safety of cocaine hydrochloride[1].

Competing Patents

Other patents in the field may cover similar aspects of pharmaceutical compositions, but the unique combination of components and methods of use in this patent sets it apart. This uniqueness is crucial for establishing the patent's validity and enforceability.

Economic and Legal Implications

Market Potential

The patent has significant market potential due to the therapeutic applications of cocaine hydrochloride. The novel compositions and methods of use could lead to new products that fill unmet medical needs, thereby generating substantial revenue.

Regulatory Compliance

The patent holder must comply with regulatory requirements, including those related to the use of controlled substances like cocaine hydrochloride. This involves obtaining necessary approvals from regulatory bodies and adhering to strict manufacturing and distribution guidelines.

Expert Insights

Industry Experts

Industry experts in pharmaceutical development highlight the importance of innovative formulations and methods of use. For example, Dr. Alan Marco, former Chief Economist for the USPTO, emphasizes the need for detailed patent claims to protect intellectual property while allowing for innovation and competition[3].

Statistics and Data

Patent Data

The USPTO's Patent Claims Research Dataset provides insights into the scope and complexity of patent claims. For instance, the dataset shows that patents with detailed claims, like those in US 10,987,347, are more likely to be granted and enforced effectively[3].

Conclusion

United States Patent 10,987,347 represents a significant advancement in the field of pharmaceutical compositions, particularly those involving cocaine hydrochloride. The patent's detailed claims and methods of use provide a comprehensive framework for the development and application of these compositions. Understanding the scope, claims, and therapeutic applications of this patent is crucial for both researchers and industry professionals looking to innovate and comply with regulatory standards.

Key Takeaways

  • Novel Compositions: The patent introduces novel pharmaceutical compositions containing cocaine hydrochloride.
  • Therapeutic Applications: These compositions are designed for various medical applications, including local anesthesia and nasal decongestion.
  • Detailed Claims: The patent includes detailed independent and dependent claims that protect the intellectual property.
  • Regulatory Compliance: Compliance with regulatory requirements is essential for the development and distribution of these compositions.
  • Market Potential: The patent has significant market potential due to its therapeutic applications.

FAQs

Q: What is the primary active ingredient in the pharmaceutical compositions described in US 10,987,347?

A: The primary active ingredient is cocaine hydrochloride.

Q: What are the main therapeutic applications of the compositions described in the patent?

A: The compositions are designed for various medical applications, including local anesthesia, nasal decongestion, and topical pain relief.

Q: How does the patent distinguish itself from prior art?

A: The patent introduces novel formulations and methods of use that enhance the therapeutic efficacy and safety of cocaine hydrochloride.

Q: What regulatory compliance is required for the development and distribution of these compositions?

A: The patent holder must comply with regulatory requirements related to the use of controlled substances like cocaine hydrochloride, including obtaining necessary approvals and adhering to strict manufacturing and distribution guidelines.

Q: What is the significance of detailed claims in the patent?

A: Detailed claims protect the intellectual property and ensure that the patent is granted and enforced effectively.

Sources

  1. US10987347B1 - Pharmaceutical compositions and methods of using the same - Google Patents
  2. U.S. Patent and Trademark Office (USPTO) - USA.gov
  3. Patent Claims Research Dataset - USPTO
  4. Search for patents - USPTO
  5. U.S. Patent Small Claims Court - ACUS

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,987,347

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Noden Pharma GOPRELTO cocaine hydrochloride SOLUTION;NASAL 209963-001 Dec 14, 2017 RX Yes Yes ⤷  Try for Free ⤷  Try for Free METHOD OF ADMINISTERING A LOCAL ANESTHETIC TO THE MUCOUS MEMBRANES IN PATIENTS WITH HEPATIC IMPAIRMENT ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.